CLASS III Drug recall · Reported 22 Nov 2017 · FDA Enforcement Report

Enalapril Maleate Tablets, USP, 5 mg (10 recalled

Amerisource Health Services is recalling Enalapril Maleate Tablets, USP, 5 mg (10 x, distributed nationwide in the US. The recall was initiated on 29 Aug 2017 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #:167194; Exp. 12/31/2018
Quantity recalled93,600 tablets

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0074-2018
FDA event ID
78118
Recalling firm
Amerisource Health Services, Columbus, OH
Classification
Class III
Status
Terminated
Recall initiated
29 Aug 2017
FDA classified
10 Nov 2017
Reported
22 Nov 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

29 Aug 2017Recall initiated by company
10 Nov 2017Classified by FDA+73 days
22 Nov 2017Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Stability Specifications

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only. Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-390-01

Where it was distributed

Nationwide USA and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Failed Stability Specifications

Which lots are affected?

Lot #:167194; Exp. 12/31/2018

Where was it sold?

Nationwide USA and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Amerisource Health Services

All 69

Other Enalapril recalls

All 21